Honig L S, Rosenberg R N
Department of Neurology, UT Southwestern Medical Center, Dallas, Texas 75235-9036, USA.
Am J Med. 2000 Mar;108(4):317-30. doi: 10.1016/s0002-9343(00)00291-6.
Many neurological disorders involve cell death. During development of the nervous system, cell death is a normal feature. Elimination of substantial numbers of initially generated cells enables useful pruning of "mismatched" or excessive cells produced by exuberance during the proliferative and migratory phases of development. Such cell death, occurring by "programmed" pathways, is termed apoptosis. In mature organisms, cells die in two major fashions, either by necrosis or apoptosis. In the adult nervous system, because there is little cell production during adulthood, there is little normal cell death. However, neurological disease is often associated with significant neural cell death. Acute disorders, occurring over minutes to hours, such as brain trauma, infarction, hemorrhage, or infection, prominently involve cell death, much of which is by necrosis. Chronic disorders, with relatively slow central nervous system degeneration, may occur over years or decades, but may involve cell losses. Such disorders include motor neuron diseases such as amyotrophic lateral sclerosis (ALS), cerebral dementing disorders such as Alzheimer's disease and frontotemporal dementia, and a variety of degenerative movement disorders including Parkinson's disease, Huntington's disease, and the inherited ataxias. There is evidence that the mechanism of neuronal cell death in these disorders may involve apoptosis. Direct conclusive evidence of apoptosis is scarce in these chronic disorders, because of the swiftness of cell death in relation to the slowness of the disease. Thus, at any particular time point of assessment, very few cells would be expected to be undergoing death. However, it is clearly of importance to define the type of cell death in these disorders. Of significance is that while treating the underlying causes of these conditions is an admirable goal, it may also be possible to develop productive therapies based on alleviating the process of cell death. This is particularly likely if this cell loss is through apoptosis, a programmed process for which the molecular cascade is increasingly understood. This article reviews our understanding of apoptosis in the nervous system, concentrating on its possible roles in chronic neurodegenerative disorders.
许多神经系统疾病都涉及细胞死亡。在神经系统发育过程中,细胞死亡是一种正常现象。大量最初生成的细胞被清除,有助于对发育增殖和迁移阶段过度生成的“不匹配”或多余细胞进行有效修剪。这种通过“程序性”途径发生的细胞死亡被称为凋亡。在成熟生物体中,细胞以两种主要方式死亡,即坏死或凋亡。在成体神经系统中,由于成年期细胞生成很少,正常的细胞死亡也很少。然而,神经系统疾病通常与大量神经细胞死亡相关。急性疾病,在数分钟到数小时内发生,如脑外伤、梗死、出血或感染,显著涉及细胞死亡,其中大部分是坏死。慢性疾病,中枢神经系统退化相对缓慢,可能在数年或数十年内发生,但可能涉及细胞丢失。这类疾病包括运动神经元疾病,如肌萎缩侧索硬化症(ALS),脑痴呆症,如阿尔茨海默病和额颞叶痴呆,以及各种退行性运动障碍,包括帕金森病、亨廷顿舞蹈病和遗传性共济失调。有证据表明,这些疾病中神经元细胞死亡的机制可能涉及凋亡。在这些慢性疾病中,凋亡的直接确凿证据很少,因为细胞死亡速度相对于疾病的缓慢程度而言很快。因此,在任何特定的评估时间点,预计正在经历死亡的细胞很少。然而,明确这些疾病中细胞死亡的类型显然很重要。重要的是,虽然治疗这些疾病的根本原因是一个值得称赞的目标,但也有可能基于减轻细胞死亡过程开发有效的治疗方法。如果这种细胞丢失是通过凋亡发生的,这种可能性尤其大,凋亡是一个程序性过程,其分子级联反应越来越为人所理解。本文综述了我们对神经系统中凋亡的理解,重点关注其在慢性神经退行性疾病中可能发挥的作用。